Corporate Evaluation
The Board of Directors of Genome British Columbia and its management are committed to the principles of public accountability and transparency. To that end, and as required by its by-laws, the Board arranged for two full-scale evaluations of Genome BC’s activities.
The purpose of the evaluations was to assess Genome BC’s achievements against its objectives and to provide information that will be used in upcoming business planning processes. The reports present findings pertaining to all facets of the organization, including scientific and management operations, GE³LS and communications and outreach activities.
The first evaluation study was completed by BearingPoint in December, 2004. The second report was completed by Dennis Rank and Associates in June, 2010.
